Patel Sunil
SEC CIK 1503062 · EDGAR
BoughtSold
Most active insiders at OABI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOEHR MATTHEW W | Pres, CEO, Dir | — | $143.5K |
| 2 | HIGGINS JOHN L | Dir | $107.7K | — |
| 3 | GUSTAFSON KURT A | CFO, Executive VP, Fin | — | $84.7K |
| 4 | Berkman Charles S | CLO | — | $54.9K |
| 5 | Crouse Steven C. | Dir | — | — |
| 6 | Gotwals Philip J | Dir | — | — |
| 7 | Cochran Jennifer R. | Dir | — | — |
| 8 | Bertozzi Carolyn R | Dir | — | — |
| 9 | Love Steven | Dir | — | — |
Patel Sunil made no open-market trades at OABI in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-01 | 2023-01-30 | OABI | OmniAb, Inc. | Patel Sunil | Dir | A - Grant | $0.00 | +8,753 | 224.3K | +4% | $0 |
| 2022-11-10 | 2022-11-09 | OABI | OmniAb, Inc. | Patel Sunil | Dir | P - Purchase | $2.77 | +43.0K | 215.5K | +25% | +$119.1K | |
| D | 2022-11-03 | 2022-11-01 | OABI | OmniAb, Inc. | Patel Sunil | Dir | A - Grant | — | +172.5K | 172.5K | New | — |
| D | 2022-11-03 | 2022-11-01 | LGND | LIGAND PHARMACEUTICALS INC | Patel Sunil | Former Dir | D - Sale to Iss | — | -1,004 | 28.8K | -3% | — |
| D | 2022-06-13 | 2022-06-10 | LGND | LIGAND PHARMACEUTICALS INC | Patel Sunil | Dir | A - Grant | $0.00 | +1,004 | 29.8K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations